期刊文献+

无创性肢体缺血预适应对大鼠缺血再灌注损伤心肌基质金属蛋白酶的影响 被引量:3

Effect of noninvasive limb ischemic preconditioning on myocardium matris metalloproteinases induced by ischemia/reperfusion in rats
下载PDF
导出
摘要 目的观察大鼠无创性肢体缺血预适应(LIP)对心肌缺血再灌注损伤后心肌形态学、梗死面积和心肌MMP-2、MMP-9和TIMP-1的影响。方法通过连续3 d每天1次3个循环的下肢无创性5 min缺血、5 min再灌建立LIP模型。大鼠随机分成3组,心肌缺血再灌注组(I/R)、心肌缺血预适应组(CIP)和LIP组。以HE染色法观察心肌形态学改变;红四氮唑染色法确定心肌梗死范围,IS=IA/AAR×100%;免疫组化法测定心肌MMP-2、MMP-9和TIMP-1水平。结果缺血30 min再灌注120 min后,I/R组IS为(44.5±8.1)%;与I/R组比较,CIP和LIP均能明显改善心肌损伤的形态学改变,降低心肌细胞的肿胀、减少间质出血和炎性细胞的浸润。CIP使IS降低35.7%,缺血区心肌MMP-2降低42.1%,MMP-9降低43.3%,TIMP-1水平增加40.0%;LIP使IS降低42.9%,缺血区心肌MMP-2降低41.2%,MMP-9降低46.6%,TIMP-1水平增加53.8%。结论LIP不仅能改善缺血再灌注损伤大鼠心肌形态学改变、减少心肌梗死面积,而且能降低心肌细胞基质的损伤,起到保护心肌的作用。 Objective To determine whether noninvasive limb ischemic preconditioning (LIP) produces cardioprotective effect on ischemia-reperfused myocardium and to observe the role of matris metalloproteinases (MMPs) in this effect. Methods LIP was performed in rats by a repeated three-cycle (5 min ischemia 5 rain reperfusion) of hind limb everyday for three days. The rats were randomly divided into 3 groups: I/R group, myocardial ischemic preconditioning (CIP) group and LIP group. The morphologic changes were observed using HE dyeing. The area at risk (AAR) and infarct area (IA) were determined using Trypan blue and triphenyl tetrazolium choride (TTC) staining respectively. The infarct size (IS) was defined as IA/AAR 100%. MMP-2,MMP-9 and TIMP-1 in different myocardial areas were determined by immunohistochemistry. Results During 30 min myocardial ischemia and subsequent 120 rain reperfusion, the IS was (44. 5 ± 8.1 )%. Comparing with I/R, the myocardial swelling, inter-stitial hemorrhage and inflammatory cell infiltrate decreased in both of CIP group and LIP group, and the IS reduced 35.7% in CIP group and 42. 9% in LIP group. The level of MMP-2, MMP-9 decreased in CIP group (42. 1% and 43.3% ) and LIP group was 41.2% and 46. 6%, but the level of TIMP-1 increased in CIP group (40. 0% ) and LIP group (53.8%). Conclusion LIP only reduces the infarct area in myocardium but also prevents cardiac matrix from degrading after the myocardial ischemia-reperfusion. The MMPs play an important role in the myocardial protection provided by LIP.
出处 《基础医学与临床》 CSCD 北大核心 2007年第12期1343-1346,共4页 Basic and Clinical Medicine
基金 天津市自然科学基金(003608411)
关键词 肢体 缺血预适应 心肌保护 缺血再灌损伤 基质金属蛋白酶 limb ischemic preconditioning myocardium cardioprotection ischemia/reperfusion injury matris metalloproteinases
  • 相关文献

参考文献9

  • 1Giricz Z, Lalu MM, Csonka C, et al. Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition [ J ]. J Pharmacol Exp Ther, 2006,316( 1 ) :154- 161.
  • 2Lang SC, Elsasser A, Scheler C, et al. Myocardial preconditioning and remote renal preconditioning-identifying a protective factor using proteomic methods [ J ] Basic Res Cardiol, 2006, 101(2) :149 -158.
  • 3Yeh CH, Lin Yu-min, Wu Yi-Cheng, et al. Inhibition of NF-kappa B activation can attenuate ischemia/reperfusioninduced contractility impairment via decreasing cardiomyocytic proinflammatory gene uP-regulation and matrix metal- loproteinase expression [ J ]. J Cardiovasc Pharmacol, 2005,45 (4) :301 - 39.
  • 4谢瑞芹,李荣芹,崔炜,郝玉明,李保华,吴金凤,杜国英,张涛,刘凡.猪骨骼肌缺血预适应降低心肌缺血再灌注后基质金属蛋白酶的表达[J].基础医学与临床,2006,26(3):280-283. 被引量:2
  • 5Schulze CJ, Wang Wenjie, Suarez-Pinzon WL, et al. Imbalance between tissue inhibitor of metalloproteinase-4 andmatrix metalloproteinases during acute myocardial [ correction of myoctardial] ischemia-reperfusion injury [ J ]. Circulation, 2003,107 (19) :2487 - 2492.
  • 6马万里,叶红,辛建保,白明.低氧抑制猪肺动脉平滑肌细胞MMP-2和MMP-9的表达[J].基础医学与临床,2005,25(10):910-913. 被引量:1
  • 7Alfonso-Jaume MA, Bergman MR, Mahimkar R, et al. Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB [ J ]. Am J Physiol Heart Circ Physiol, 2006, 291 (4) : H1838 - H1846.
  • 8黄荣杰,刘唐威,庞玉生.扩张型心肌病大鼠肿瘤坏死因子α及基质金属蛋白酶1的表达[J].基础医学与临床,2005,25(5):424-428. 被引量:5
  • 9Sawicki G, Menon V, Jugdutt BI. Improved balance between TIMP-3 and MMP-9 after regional myocardial ischemia-reperfusion during AT1 receptor blockade [ J ]. J Card Fail, 2004,10(5) :442 -449.

二级参考文献23

  • 1汪浩川,刘秉文,傅明德.人动脉平滑肌细胞贴块培养法[J].华西医科大学学报,1995,26(1):105-108. 被引量:35
  • 2Baig MK, Mahon N,McKenna WJ,et al. The pathophysiology of advanced heart failure[J].Am Heart J,1998,135:S216-S230.
  • 3Liao R,Nascimben L,Friedrich J,et al.Decreased energy reserve in an aplmal model of dilated cardiomyopathy. Relationship to contratile performance[J]. Circulation Res, 1996, 78:893 - 902.
  • 4Sarah M,Nakamura M,Saitoh H,et al.Tumor necrosis factor-α-converting enzyme and tumor necrosis Factor-a in human dilated cardiomyopathy [ J ]. Circulation, 1999, 99:3260 -3265.
  • 5Bradham WS,Moe G,Wendt KA,et al.TNF-α and myocardial matrix metalloproteinases in heart failure:relationship to LV remodeling[J].Am J Physiol Heart Circ Physiol,2002,282:H1288-H1295.
  • 6Torre-Amione G,Kapadia S,Lee J,et al.Expression and functional significance of tumor necrosis factor receptors in human myocardium[J]. Circulation, 1995,92:1487- 1491.
  • 7Sash M, Nakamura M, Tamura G, et al. Inducible nitric oxide synthase and tumor necrosis facet-alpha in myocardium in human dilated cardiomyopathy[J]. J Am Coil Cadiol,1997,29:716-724.
  • 8Bryant D,Becker L,Richardson J,et al.Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α[J]. Circulation, 1998,97:1375- 1381.
  • 9Li,YY,Feng YQ,Kadokami T,et al.Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy[J].Proc Natl Acad Sci USA,2000,97:12746-12751.
  • 10Li YY,Kadokami T,Wang P,et al.MMP inhibition modulates TNF-αtransgenic mouse phenotype early in the development of heart failure[J]. Am J Physiol Heart Circ Physiol,2002,282:H983 - H989.

共引文献4

同被引文献17

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部